DarioHealth (DRIO) Competitors $13.69 +4.10 (+42.75%) Closing price 09/25/2025 04:00 PM EasternExtended Trading$12.02 -1.68 (-12.24%) As of 04:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DRIO vs. TELA, SURG, CTSO, DXR, PYPD, SRTS, MDAI, GUTS, APT, and WOKShould you be buying DarioHealth stock or one of its competitors? The main competitors of DarioHealth include TELA Bio (TELA), SurgePays (SURG), Cytosorbents (CTSO), Daxor (DXR), PolyPid (PYPD), Sensus Healthcare (SRTS), Spectral AI (MDAI), Fractyl Health (GUTS), Alpha Pro Tech (APT), and WORK Medical Technology Group (WOK). These companies are all part of the "medical equipment" industry. DarioHealth vs. Its Competitors TELA Bio SurgePays Cytosorbents Daxor PolyPid Sensus Healthcare Spectral AI Fractyl Health Alpha Pro Tech WORK Medical Technology Group TELA Bio (NASDAQ:TELA) and DarioHealth (NASDAQ:DRIO) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations. Which has more risk & volatility, TELA or DRIO? TELA Bio has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500. Comparatively, DarioHealth has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500. Do analysts rate TELA or DRIO? TELA Bio currently has a consensus price target of $4.50, suggesting a potential upside of 204.05%. DarioHealth has a consensus price target of $40.00, suggesting a potential upside of 192.18%. Given TELA Bio's higher probable upside, analysts plainly believe TELA Bio is more favorable than DarioHealth.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TELA Bio 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50DarioHealth 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Is TELA or DRIO more profitable? TELA Bio has a net margin of -54.12% compared to DarioHealth's net margin of -162.73%. DarioHealth's return on equity of -65.89% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets TELA Bio-54.12% -329.48% -57.34% DarioHealth -162.73%-65.89%-39.03% Which has higher earnings & valuation, TELA or DRIO? TELA Bio has higher revenue and earnings than DarioHealth. TELA Bio is trading at a lower price-to-earnings ratio than DarioHealth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTELA Bio$69.30M0.85-$37.84M-$1.12-1.32DarioHealth$27.04M1.15-$42.75M-$13.20-1.04 Do insiders and institutionals have more ownership in TELA or DRIO? 94.4% of TELA Bio shares are held by institutional investors. Comparatively, 33.4% of DarioHealth shares are held by institutional investors. 4.7% of TELA Bio shares are held by insiders. Comparatively, 11.2% of DarioHealth shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media refer more to TELA or DRIO? In the previous week, DarioHealth had 6 more articles in the media than TELA Bio. MarketBeat recorded 8 mentions for DarioHealth and 2 mentions for TELA Bio. TELA Bio's average media sentiment score of 1.47 beat DarioHealth's score of 0.57 indicating that TELA Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TELA Bio 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DarioHealth 1 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryDarioHealth beats TELA Bio on 9 of the 16 factors compared between the two stocks. Get DarioHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for DRIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DRIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DRIO vs. The Competition Export to ExcelMetricDarioHealthMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.82M$6.74B$5.74B$10.39BDividend YieldN/A1.22%5.75%4.64%P/E Ratio-1.0425.0375.7726.11Price / Sales1.15196.58544.59124.93Price / CashN/A21.5437.5461.24Price / Book0.325.0112.876.30Net Income-$42.75M$178.07M$3.29B$271.03M7 Day Performance107.42%-0.74%0.26%-0.14%1 Month Performance30.68%5.20%2.85%5.82%1 Year Performance-29.43%21.95%65.65%27.63% DarioHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DRIODarioHealth1.4558 of 5 stars$13.69+42.8%$40.00+192.2%-25.3%$21.82M$27.04M-1.04200News CoverageGap DownHigh Trading VolumeTELATELA Bio2.8265 of 5 stars$1.58flat$4.50+184.8%-39.8%$62.59M$75.32M-1.41120SURGSurgePays3.3643 of 5 stars$3.05+2.7%$9.00+195.1%+83.3%$60.68M$60.88M-1.2240News CoverageCTSOCytosorbents2.077 of 5 stars$0.92-2.5%$5.50+500.9%-28.8%$58.90M$35.60M-5.38220DXRDaxor3.8517 of 5 stars$11.64-0.2%$25.00+114.8%+30.4%$56.40M$3.31M0.0037PYPDPolyPid3.2707 of 5 stars$3.39-2.3%$12.40+265.8%-6.9%$55.16MN/A-0.8980Positive NewsSRTSSensus Healthcare2.578 of 5 stars$3.15-0.9%$8.00+154.0%-43.5%$52.28M$37.56M-52.5040Analyst DowngradeMDAISpectral AI2.7713 of 5 stars$1.99+2.6%$3.50+75.9%+126.3%$51.86M$27.55M-2.8883News CoverageGap UpGUTSFractyl Health2.3509 of 5 stars$0.98-3.7%$7.15+628.1%-57.2%$51.30M$17K-0.48102Gap UpHigh Trading VolumeAPTAlpha Pro Tech1.5325 of 5 stars$4.84-1.0%N/A-13.8%$50.69M$58.56M13.08120WOKWORK Medical Technology GroupN/A$0.80flatN/A-98.2%$45.60M$11.51M0.00226News CoveragePositive NewsHigh Trading Volume Related Companies and Tools Related Companies TELA Alternatives SURG Alternatives CTSO Alternatives DXR Alternatives PYPD Alternatives SRTS Alternatives MDAI Alternatives GUTS Alternatives APT Alternatives WOK Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DRIO) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredNew Buy Alert: Should you put $1,000 into Oracle (ORCL) now?Barron's is calling this Oracle's "Nvidia Moment..." While the Wall Street Journal is simply calling Oracle...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DarioHealth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share DarioHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DRIO Stock Alerts